mRNA directs body to produce nanobodies that unlock immune attack on colorectal cancer tumors

A tiny molecule called a nanobody may succeed where today’s cancer drugs often fail, according to University of Hawaiʻi at Mānoa researcher Stefan Moisyadi, who has been refining the concept for nearly a decade.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup